The blood-brain barrier and methamphetamine: Open sesame?

Frontiers in Neuroscience

Volumn 9, Issue APR, 2015, Pages

  Turowski, Patric ^a   Kenny, Bridget Ann ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Blood brain barrier; CNS chemotherapy; Endothelial cell; Methamphetamine; Neuroinflammation; Neurovascular unit; Pinocytosis; Tight junctions

Indexed keywords

METHAMPHETAMINE;

ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN CELL; CENTRAL NERVOUS SYSTEM; ENDOTHELIUM CELL; EXCITOTOXICITY; HUMAN; MACROPHAGE; MICROGLIA; NEUROMODULATION; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PERICYTE; SHORT SURVEY; TIGHT JUNCTION; VASCULAR ENDOTHELIUM;

EID: 84928683075     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2015.00156     Document Type: Short Survey

References (57)

1. Abbott, N. J., Patabendige, A. A., Dolman, D. E., Yusof, S. R. and Begley, D. J. (2010). Structure and function of the blood-brain barrier. Neurobiol. Dis. 37, 13-25.
2. Alvarez, J. I., Cayrol, R. and Prat, A. (2011). Disruption of central nervous system barriers in multiple sclerosis. Biochim. Biophys. Acta. 1812, 252-64.
3. Argaw, A. T., Asp, L., Zhang, J., Navrazhina, K., Pham, T., Mariani, J. N., et al. (2012). Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease. J. Clin. Invest. 122, 2454-68.
4. Armulik, A., Genove, G. and Betsholtz, C. (2011). Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev. Cell. 21, 193-215.
5. Armulik, A., Genove, G., Mae, M., Nisancioglu, M. H., Wallgard, E., Niaudet, C., et al. (2010). Pericytes regulate the blood-brain barrier. Nature. 468, 557-61.
6. Bowyer, J. F., Robinson, B., Ali, S. and Schmued, L. C. (2008). Neurotoxic-related changes in tyrosine hydroxylase, microglia, myelin, and the blood-brain barrier in the caudate-putamen from acute methamphetamine exposure. Synapse. 62, 193-204.
7. Bunzow, J. R., Sonders, M. S., Arttamangkul, S., Harrison, L. M., Zhang, G., Quigley, D. I., et al. (2001). Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol. Pharmacol. 60, 1181-8.
8. Capeloa, T., Caramelo, F., Fontes-Ribeiro, C., Gomes, C. and Silva, A. P. (2014). Role of methamphetamine on glioblastoma cytotoxicity induced by doxorubicin and methotrexate. Neurotox. Res. 26, 216-27.
9. Conant, K., St Hillaire, C., Anderson, C., Galey, D., Wang, J. and Nath, A. (2004). Human immunodeficiency virus type 1 Tat and methamphetamine affect the release and activation of matrix-degrading proteinases. J. Neurovirol. 10, 21-8.
10. Cook, C. E., Jeffcoat, A. R., Sadler, B. M., Hill, J. M., Voyksner, R. D., Pugh, D. E., et al. (1992). Pharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans. Drug. Metab. Dispos. 20, 856-62.
11. Daneman, R. (2012). The blood-brain barrier in health and disease. Ann. Neurol. 72, 648-72.
12. Daneman, R., Zhou, L., Kebede, A. A. and Barres, B. A. (2010). Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature. 468, 562-6.
13. Dejana, E. and Orsenigo, F. (2013). Endothelial adherens junctions at a glance. J. Cell. Sci. 126, 2545-9.
14. Denieffe, S., Kelly, R. J., McDonald, C., Lyons, A. and Lynch, M. A. (2013). Classical activation of microglia in CD200-deficient mice is a consequence of blood brain barrier permeability and infiltration of peripheral cells. Brain. Behav. Immun. 34, 86-97.
15. Drozdzik, M., Bialecka, M., Mysliwiec, K., Honczarenko, K., Stankiewicz, J. and Sych, Z. (2003). Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease. Pharmacogenetics. 13, 259-63.
16. El Ali, A., Urrutia, A., Rubio-Araiz, A., Hernandez-Jimenez, M., Colado, M. I., Doeppner, T. R., et al. (2012). Apolipoprotein-E controls adenosine triphosphatebinding cassette transporters ABCB1 and ABCC1 on cerebral microvessels after methamphetamine intoxication. Stroke. 43, 1647-53.
17. Engelhardt, B. and Wolburg, H. (2004). Mini-review: Transendothelial migration of leukocytes: through the front door or around the side of the house? Eur. J. Immunol. 34, 2955-63.
18. Focosi, D. and Kast, R. E. (2010). Improving imatinib delivery to central nervous system. Intern. Med. J. 40, 318-9.
19. Friedrich, A., Prasad, P. D., Freyer, D., Ganapathy, V. and Brust, P. (2003). Molecular cloning and functional characterization of the OCTN2 transporter at the RBE4 cells, an in vitro model of the blood-brain barrier. Brain. Res. 968, 69-79.
20. Goncalves, J., Martins, T., Ferreira, R., Milhazes, N., Borges, F., Ribeiro, C. F., et al. (2008). Methamphetamine-induced early increase of IL-6 and TNF-alpha mRNA expression in the mouse brain. Ann. N. Y. Acad. Sci. 1139, 103-11.
21. Hofman, P., Blaauwgeers, H. G., Tolentino, M. J., Adamis, A. P., Nunes Cardozo, B. J., Vrensen, G. F., et al. (2000). VEGF-A induced hyperpermeability of blood-retinal barrier endothelium in vivo is predominantly associated with pinocytotic vesicular transport and not with formation of fenestrations. Vascular endothelial growth factor- A. Curr. Eye. Res. 21, 637-45.
22. Hudson, N., Powner, M. B., Sarker, M. H., Burgoyne, T., Campbell, M., Ockrim, Z. K., et al. (2014). Differential apicobasal VEGF signaling at vascular blood-neural barriers. Dev. Cell. 30, 541-52.
23. Jeynes, B. and Provias, J. (2011). The case for blood-brain barrier dysfunction in the pathogenesis of Alzheimer's disease. J. Neurosci. Res. 89, 22-8.
24. Kast, R. E. (2007). Using blood brain barrier disruption by methamphetamine for drug delivery. J. Neurooncol. 85, 109-10.
25. Kiyatkin, E. A., Brown, P. L. and Sharma, H. S. (2007). Brain edema and breakdown of the blood-brain barrier during methamphetamine intoxication: critical role of brain hyperthermia. Eur. J. Neurosci. 26, 1242-53.
26. Kousik, S. M., Graves, S. M., Napier, T. C., Zhao, C. and Carvey, P. M. (2011). Methamphetamine-induced vascular changes lead to striatal hypoxia and dopamine reduction. Neuroreport. 22, 923-8.
27. Kuroda, Y., Kitada, M., Wakao, S., Nishikawa, K., Tanimura, Y., Makinoshima, H., et al. (2010). Unique multipotent cells in adult human mesenchymal cell populations. Proc. Natl. Acad. Sci. U S A. 107, 8639-43.
28. Liu, L. B., Xue, Y. X. and Liu, Y. H. (2010). Bradykinin increases the permeability of the blood-tumor barrier by the caveolae-mediated transcellular pathway. J. Neurooncol. 99, 187-94.
29. Lo, E. H., Dalkara, T. and Moskowitz, M. A. (2003). Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci. 4, 399-415.
30. Mahajan, S. D., Aalinkeel, R., Sykes, D. E., Reynolds, J. L., Bindukumar, B., Adal, A., et al. (2008). Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuse. Brain. Res. 1203, 133-48.
31. Martins, T., Baptista, S., Goncalves, J., Leal, E., Milhazes, N., Borges, F., et al. (2011). Methamphetamine transiently increases the blood-brain barrier permeability in the hippocampus: role of tight junction proteins and matrix metalloproteinase-9. Brain. Res. 1411, 28-40.
32. Martins, T., Burgoyne, T., Kenny, B. A., Hudson, N., Futter, C. E., Ambrosio, A. F., et al. (2013). Methamphetamine-induced nitric oxide promotes vesicular transport in blood-brain barrier endothelial cells. Neuropharmacology. 65, 74-82.
33. Melega, W. P., Cho, A. K., Harvey, D. and Lacan, G. (2007). Methamphetamine blood concentrations in human abusers: application to pharmacokinetic modeling. Synapse. 61, 216-20.
34. Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., et al. (2015). Blood-brain barrier breakdown in the aging human hippocampus. Neuron. 85, 296-302.
35. Nag, S., Venugopalan, R. and Stewart, D. J. (2007). Increased caveolin-1 expression precedes decreased expression of occludin and claudin-5 during blood-brain barrier breakdown. Acta. Neuropathol. 114, 459-69.
36. Nitta, T., Hata, M., Gotoh, S., Seo, Y., Sasaki, H., Hashimoto, N., et al. (2003). Size selective loosening of the blood-brain barrier in claudin-5-deficient mice. J. Cell. Biol. 161, 653-60.
37. O'Shea, E., Urrutia, A., Green, A. R. and Colado, M. I. (2014). Current preclinical studies on neuroinflammation and changes in blood-brain barrier integrity by MDMA and methamphetamine. Neuropharmacology. 87, 125-34.
38. Park, M., Hennig, B. and Toborek, M. (2012). Methamphetamine alters occludin expression via NADPH oxidase-induced oxidative insult and intact caveolae. J. Cell. Mol. Med. 16, 362-75.
39. Park, M., Kim, H. J., Lim, B., Wylegala, A. and Toborek, M. (2013). Methamphetamine-induced occludin endocytosis is mediated by the Arp2/3 complexregulated actin rearrangement. J. Biol. Chem. 288, 33324-34.
40. Patel, M. M., Goyal, B. R., Bhadada, S. V., Bhatt, J. S. and Amin, A. F. (2009). Getting into the brain: approaches to enhance brain drug delivery. CNS. drugs. 23, 35-58.
41. Petzold, G. C. and Murthy, V. N. (2011). Role of astrocytes in neurovascular coupling. Neuron. 71, 782-97.
42. Quinton, M. S. and Yamamoto, B. K. (2006). Causes and consequences of methamphetamine and MDMA toxicity. AAPS. J. 8, E337-47.
43. Ramirez, S. H., Potula, R., Fan, S., Eidem, T., Papugani, A., Reichenbach, N., et al. (2009). Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells. J. Cereb. Blood. Flow. Metab. 29, 1933-45.
44. Ransohoff, R. M. and Engelhardt, B. (2012). The anatomical and cellular basis of immune surveillance in the central nervous system. Nat. Rev. Immunol. 12, 623-35.
45. Sardi, I. (2011). Morphine facilitates doxorubicin penetration in the central nervous system: a new prospect for therapy of brain tumors. J. Neurooncol. 104, 619-20.
46. Saunders, N. R., Daneman, R., Dziegielewska, K. M. and Liddelow, S. A. (2013). Transporters of the blood-brain and blood-CSF interfaces in development and in the adult. Mol. Aspects. Med. 34, 742-52.
47. Sharma, H. S. and Kiyatkin, E. A. (2009). Rapid morphological brain abnormalities during acute methamphetamine intoxication in the rat: an experimental study using light and electron microscopy. J. Chem. Neuroanat. 37, 18-32.
48. Shue, E. H., Carson-Walter, E. B., Liu, Y., Winans, B. N., Ali, Z. S., Chen, J., et al. (2008). Plasmalemmal vesicle associated protein-1 (PV-1) is a marker of blood-brain barrier disruption in rodent models. BMC. Neurosci. 9, 29.
49. Stamatovic, S. M., Keep, R. F. and Andjelkovic, A. V. (2008). Brain endothelial cellcell junctions: how to "open" the blood brain barrier. Curr. Neuropharmacol. 6, 179-92.
50. Steed, E., Balda, M. S. and Matter, K. (2010). Dynamics and functions of tight junctions. Trends. Cell. Biol. 20, 142-9.
51. Takayasu, T., Ohshima, T., Nishigami, J., Kondo, T. and Nagano, T. (1995). Screening and determination of methamphetamine and amphetamine in the blood, urine and stomach contents in emergency medical care and autopsy cases. J. Clin. Forensic. Med. 2, 25-33.
52. Terrando, N., Yang, T., Ryu, J. K., Newton, P. T., Monaco, C., Feldmann, M., et al. (2014). Stimulation of the alpha 7 nicotinic acetylcholine receptor protects against neuroinflammation after tibia fracture and endotoxemia in mice. Mol. Med.in press.
53. Urrutia, A., Rubio-Araiz, A., Gutierrez-Lopez, M. D., El Ali, A., Hermann, D. M., O'Shea, E., et al. (2013). A study on the effect of JNK inhibitor, SP600125, on the disruption of blood-brain barrier induced by methamphetamine. Neurobiol. Dis. 50, 49-58.
54. Van Teeffelen, J. W., Brands, J., Stroes, E. S. and Vink, H. (2007). Endothelial glycocalyx: sweet shield of blood vessels. Trends. Cardiovasc. Med. 17, 101-5.
55. Wu, X., Kekuda, R., Huang, W., Fei, Y. J., Leibach, F. H., Chen, J., et al. (1998a). Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J Biol. Chem. 273, 32776-86.
56. Wu, X., Prasad, P. D., Leibach, F. H. and Ganapathy, V. (1998b). cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem. Biophys. Res. Commun. 246, 589-95.
57. Zhao, L. N., Yang, Z. H., Liu, Y. H., Ying, H. Q., Zhang, H. and Xue, Y. X. (2011). Vascular endothelial growth factor increases permeability of the blood-tumor barrier via caveolae-mediated transcellular pathway. J. Mol. Neurosci. 44, 122-9.